NZ Parsa

1.6k total citations
19 papers, 1.3k citations indexed

About

NZ Parsa is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Genetics. According to data from OpenAlex, NZ Parsa has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 7 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in NZ Parsa's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Myeloid Leukemia Research (2 papers). NZ Parsa is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Myeloid Leukemia Research (2 papers). NZ Parsa collaborates with scholars based in United States, France and Italy. NZ Parsa's co-authors include RS Chaganti, Kenneth Offit, DC Louie, D Filippa, Gianluca Gaïdano, S.C. Jhanwar, Riccardo Dalla‐Favera, Olli Kallioniemi, Stephen P. Ethier and Anne Kallioniemi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

NZ Parsa

19 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
NZ Parsa United States 15 623 514 430 408 247 19 1.3k
Jin Hong Liu United States 14 357 0.6× 437 0.9× 437 1.0× 333 0.8× 101 0.4× 15 1.3k
S Hirosawa Japan 18 259 0.4× 310 0.6× 470 1.1× 231 0.6× 145 0.6× 34 1.1k
John H. Proffitt United States 15 447 0.7× 204 0.4× 444 1.0× 438 1.1× 93 0.4× 17 1.1k
Tim Svenstrup Poulsen Denmark 17 309 0.5× 323 0.6× 324 0.8× 194 0.5× 112 0.5× 71 896
Andreas Tobler Switzerland 24 165 0.3× 394 0.8× 705 1.6× 204 0.5× 127 0.5× 49 1.2k
Trang Le Austria 16 274 0.4× 179 0.3× 475 1.1× 336 0.8× 91 0.4× 38 988
K. Autio Finland 17 277 0.4× 274 0.5× 693 1.6× 230 0.6× 483 2.0× 32 1.6k
Mònica López‐Guerra Spain 21 393 0.6× 331 0.6× 737 1.7× 481 1.2× 132 0.5× 61 1.3k
Lippman Sm United States 9 327 0.5× 221 0.4× 346 0.8× 125 0.3× 72 0.3× 16 807
Florence Nguyen‐Khac France 21 311 0.5× 157 0.3× 506 1.2× 454 1.1× 127 0.5× 78 1.2k

Countries citing papers authored by NZ Parsa

Since Specialization
Citations

This map shows the geographic impact of NZ Parsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NZ Parsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NZ Parsa more than expected).

Fields of papers citing papers by NZ Parsa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by NZ Parsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NZ Parsa. The network helps show where NZ Parsa may publish in the future.

Co-authorship network of co-authors of NZ Parsa

This figure shows the co-authorship network connecting the top 25 collaborators of NZ Parsa. A scholar is included among the top collaborators of NZ Parsa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with NZ Parsa. NZ Parsa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Parsa, NZ. (2012). Molecular and Cellular Basis of Human Cancer. 2(4). 365–376. 6 indexed citations
2.
Parsa, NZ. (2012). Environmental factors inducing human cancers.. PubMed. 41(11). 1–9. 140 indexed citations
3.
Forozan, Farahnaz, et al.. (1999). Molecular cytogenetic analysis of 11 new breast cancer cell lines. British Journal of Cancer. 81(8). 1328–1334. 171 indexed citations
4.
Parsa, NZ, et al.. (1997). Assignment of interferon gamma receptor (IFNGR1) to human chromosome bands 6q24.1→q24.2 by in situ hybridization. Cytogenetic and Genome Research. 76(3-4). 181–182. 1 indexed citations
5.
Houldsworth, Jane, Katerina Dyomina, DC Louie, et al.. (1996). REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood. 87(1). 25–29. 12 indexed citations
6.
Guan, Xin‐Yuan, et al.. (1996). Localization by chromosome microdissection of a recurrent breakpoint region on chromosome 6 in human B-cell lymphoma. Blood. 88(4). 1418–1422. 35 indexed citations
7.
Houldsworth, Jane, Katerina Dyomina, DC Louie, et al.. (1996). REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood. 87(1). 25–29. 171 indexed citations
8.
Offit, Kenneth, DC Louie, NZ Parsa, Ariela Noy, & RS Chaganti. (1995). Del (7)(q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features. Blood. 86(6). 2365–2370. 31 indexed citations
9.
Louie, DC, Kenneth Offit, Rebecca Jaslow, et al.. (1995). p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood. 86(8). 2892–2899. 106 indexed citations
10.
Dalla‐Favera, Riccardo, Chin‐Chen Chang, K Cechova, et al.. (1994). BCL-6 and the Molecular Pathogenesis of B-Cell Lymphoma. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 117–123. 26 indexed citations
11.
Offit, Kenneth, DC Louie, NZ Parsa, et al.. (1994). Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood. 83(9). 2611–2618. 54 indexed citations
12.
Gaïdano, Gianluca, NZ Parsa, Vittorio Tassi, et al.. (1993). In vitro establishment of AIDS-related lymphoma cell lines: phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-Barr virus infection.. PubMed. 7(10). 1621–9. 47 indexed citations
13.
Offit, Kenneth, NZ Parsa, Gianluca Gaïdano, et al.. (1993). 6q deletions define distinct clinico-pathologic subsets of non- Hodgkin's lymphoma. Blood. 82(7). 2157–2162. 163 indexed citations
14.
Gaïdano, Gianluca, NZ Parsa, Kenneth Offit, et al.. (1992). Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood. 80(7). 1781–1787. 160 indexed citations
15.
Offit, Kenneth, NZ Parsa, D Filippa, S.C. Jhanwar, & RS Chaganti. (1992). t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood. 80(10). 2594–2599. 95 indexed citations
16.
Testa, Joseph R., et al.. (1988). Two rearranged MET alleles in MNNG-HOS cells reveal the orientation of MET on chromosome 7 to other markers tightly linked to the cystic fibrosis locus.. Proceedings of the National Academy of Sciences. 85(8). 2667–2671. 17 indexed citations
17.
Barker, P E, Joseph R. Testa, NZ Parsa, & Robert L. Snyder. (1986). High molecular weight DNA from fixed cytogenetic preparations.. PubMed. 39(5). 661–8. 16 indexed citations
18.
Mukherjee, A.B., et al.. (1985). Induction of terminal differentiation and nuclear appendage(s) formation in a human myeloid leukaemia cell line (HL-60).. PubMed. 44(176). 109–18. 4 indexed citations
19.
Hogge, Donna E., S Misawa, NZ Parsa, A Pollak, & Joseph R. Testa. (1984). Abnormalities of chromosome 16 in association with acute myelomonocytic leukemia and dysplastic bone marrow eosinophils.. Journal of Clinical Oncology. 2(6). 550–557. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026